A Reconsideration of the Relevance of Systemic Low-Dose Ketamine to the Pathophysiology of Fibromyalgia
- 1 September 2006
- journal article
- review article
- Published by Elsevier in The Journal of Pain
- Vol. 7 (9) , 611-614
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Genetic basis for individual variations in pain perception and the development of a chronic pain conditionHuman Molecular Genetics, 2004
- Ketamine in Chronic Pain Management: An Evidence-Based ReviewAnesthesia & Analgesia, 2003
- Chronic widespread pain and fibromyalgia: what we know, and what we need to knowBest Practice & Research Clinical Rheumatology, 2003
- Mice Lacking D5Dopamine Receptors Have Increased Sympathetic Tone and Are HypertensiveJournal of Neuroscience, 2002
- Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to ratsEuropean Journal of Pharmacology, 2001
- Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patientsPain, 2000
- The role of dopamine in the nucleus accumbens in analgesiaLife Sciences, 1999
- Dopamine Reuptake Inhibition in the Rostral Agranular Insular Cortex Produces AntinociceptionJournal of Neuroscience, 1999
- Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromesAmerican Journal of Psychiatry, 1992
- Pain in Parkinson's diseaseMovement Disorders, 1986